Angiotensin-converting enzyme in untreated Hodgkin's disease. 1981

J L Wolf, and S J Forman, and L Gaidulis, and K G Blume

UI MeSH Term Description Entries
D007703 Peptidyl-Dipeptidase A A peptidyl-dipeptidase that catalyzes the release of a C-terminal dipeptide, oligopeptide-|-Xaa-Yaa, when Xaa is not Pro, and Yaa is neither Asp nor Glu. Thus, conversion of ANGIOTENSIN I to ANGIOTENSIN II, with increase in vasoconstrictor activity, but no action on angiotensin II. It is also able to inactivate BRADYKININ, a potent vasodilator; and has a glycosidase activity which releases GPI-anchored proteins from the membrane by cleaving the mannose linkage in the GPI moiety. (From https://www.uniprot.org April 15, 2020). ACE1 Angiotensin-Converting Enzyme 1,ACE1 Protein,Angiotensin Converting Enzyme,Angiotensin Converting Enzyme 1,Antigens, CD143,CD143 Antigens,Dipeptidyl Carboxypeptidase I,Kininase II,Peptidase P,Angiotensin I-Converting Enzyme,Carboxycathepsin,Dipeptidyl Peptidase A,Kininase A,ACE1 Angiotensin Converting Enzyme 1,Angiotensin I Converting Enzyme,Carboxypeptidase I, Dipeptidyl,Peptidyl Dipeptidase A
D006689 Hodgkin Disease A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen. Granuloma, Hodgkin,Granuloma, Malignant,Hodgkin Lymphoma,Lymphogranuloma, Malignant,Granuloma, Hodgkin's,Granuloma, Hodgkins,Hodgkin Lymphoma, Adult,Hodgkin's Disease,Hodgkin's Lymphoma,Hodgkins Disease,Lymphocyte Depletion Hodgkin's Lymphoma,Lymphocyte-Rich Classical Hodgkin's Lymphoma,Mixed Cellularity Hodgkin's Lymphoma,Nodular Lymphocyte-Predominant Hodgkin's Lymphoma,Nodular Sclerosing Hodgkin's Lymphoma,Adult Hodgkin Lymphoma,Disease, Hodgkin,Disease, Hodgkin's,Disease, Hodgkins,Hodgkin Granuloma,Hodgkin's Granuloma,Hodgkins Granuloma,Hodgkins Lymphoma,Lymphocyte Rich Classical Hodgkin's Lymphoma,Lymphogranulomas, Malignant,Lymphoma, Hodgkin,Lymphoma, Hodgkin's,Malignant Granuloma,Malignant Granulomas,Malignant Lymphogranuloma,Malignant Lymphogranulomas,Nodular Lymphocyte Predominant Hodgkin's Lymphoma

Related Publications

J L Wolf, and S J Forman, and L Gaidulis, and K G Blume
January 1985, Acta haematologica,
J L Wolf, and S J Forman, and L Gaidulis, and K G Blume
January 1984, Acta haematologica,
J L Wolf, and S J Forman, and L Gaidulis, and K G Blume
September 1985, The Journal of clinical endocrinology and metabolism,
J L Wolf, and S J Forman, and L Gaidulis, and K G Blume
December 2003, Biological trace element research,
J L Wolf, and S J Forman, and L Gaidulis, and K G Blume
January 1981, Acta medica Scandinavica,
J L Wolf, and S J Forman, and L Gaidulis, and K G Blume
May 2016, Molecular biology reports,
J L Wolf, and S J Forman, and L Gaidulis, and K G Blume
October 1985, Presse medicale (Paris, France : 1983),
J L Wolf, and S J Forman, and L Gaidulis, and K G Blume
April 1981, Irish medical journal,
J L Wolf, and S J Forman, and L Gaidulis, and K G Blume
September 1995, BMJ (Clinical research ed.),
J L Wolf, and S J Forman, and L Gaidulis, and K G Blume
January 2013, Biomeditsinskaia khimiia,
Copied contents to your clipboard!